LEP and breast carcinoma: Since autophagy inhibition has been considered as a potential cancer therapy in recent years, our data supports the potential use of autophagy inhibition in breast cancer, particularly for obese breast cancer patients with high levels of circulating leptin which are known to have an unfavorable prognosis with current therapeutic strategies.